KAZUISTIKA / CASE REPORT Euglykemická ketoacidóza asociovaná se SGLT2 inhibitory a DPP4 inhibitory – rozbor kazuistik | 121 / Anest intenziv Med. 2024;35(2):116-121 / ANESTEZIOLOGIE A INTENZIVNÍ MEDICÍNA www.aimjournal.cz 9. Thiruvenkatarajan V, Meyer EJ, Nanjappa N, Van Wijk RM, Jesudason D. Perioperative diabetic ketoacidosis associated with sodium‑glucose co‑transporter-2 inhibitors: a systematic review. Br J Anaesth. 2019;123(1):27-36. doi:10.1016/j.bja.2019. 03. 028. 10. Šitina M, Šrámek V. Patogeneze euglykemické ketoacidózy asociované se SGLT2 inhibitory. Anest intenziv Med. 2024;35(2):98-103. doi:10.36290/aim.2024.019. 11. Figge J, Rossing TH, Fencl V. The role of serum proteins in acid‑base equilibria. J Lab Clin Med. 1991;117(6):453-467. 12. Figge J, Mydosh T, Fencl V. Serum proteins and acid‑base equilibria: a follow‑up. J Lab Clin Med. 1992;120(5):713-719. 13. Fencl V, Jabor A, Kazda A, Figge J. Diagnosis of Metabolic Acid–Base Disturbances in Critically Ill Patients. Am J Respir Crit Care Med. 2000;162(6):2246-2251. doi:10.1164/ajrccm.162. 6. 9904099. 14. Kellum JA. Clinical review: reunification of acid‑base physiology. Crit Care Lond Engl. 2005;9(5):500-507. doi:10.1186/cc3789. 15. Helmersson‐Karlqvist J, Höög Hammarström K, Palmberg K, Backman‐Johansson C. Evaluation of Nova StatStrip and FreeStyle Precision Pro blood ketone tests using 3‐hydroxybutyrate doped samples. J Clin Lab Anal. 2019;33(4):e22851. doi:10.1002/jcla.22851. 16. Oh MS, Banerji MA, Carroll HJ. The mechanism of hyperchloremic acidosis during the recovery phase of diabetic ketoacidosis. Diabetes. 1981;30(4):310-313. doi:10.2337/ diab.30. 4. 310. 17. Charoenpiriya A, Chailurkit L, Ongphiphadhanakul B. Comparisons of biochemical parameters and diabetic ketoacidosis severity in adult patients with type 1 and type 2 diabetes. BMC Endocr Disord. 2022;22(1):7. doi:10.1186/s12902-021-00922-3. 18. Warming‑Larsen A. Renal excretion of ketone bodies. II. Acta Med Scand. 1952;144(3):197200. doi:10.1111/j.0954-6820.1952.tb15684.x 19. Hall JE, Hall ME. Guyton and Hall Textbook of Medical Physiology. 14th edition. Elsevier; 2021. 20. Adrogué HJ, Wilson H, Boyd AE, Suki WN, Eknoyan G. Plasma acid‑base patterns in diabetic ketoacidosis. N Engl J Med. 1982;307(26):1603-1610. doi:10.1056/ NEJM198212233072603. 21. Schwetz V, Eisner F, Schilcher G, Eller K, Plank J, Lind A, et al. Combined metformin ‑associated lactic acidosis and euglycemic ketoacidosis. Wien Klin Wochenschr. 2017 Sep;129(17-18):646-649. doi: 10.1007/s00508-017-1251-6. Epub 2017 Sep 1. PMID: 28865058; PMCID: PMC5599436. 22. Bonsignore A, Pozzi F, Fraternali Orcioni G, Ventura F, Palmiere C. Fatal metformin overdose: case report and postmortem biochemistry contribution. Int J Legal Med. 2014;128(3):483-492. doi:10.1007/s00414-013-0927-3. 23. Qi H, Nielsen PM, Schroeder M, Bertelsen LB, Palm F, Laustsen C. Acute renal metabolic effect of metformin assessed with hyperpolarised MRI in rats. Diabetologia. 2018;61(2):445454. doi:10.1007/s00125-017-4445-6. 24. Kubera B, Hubold C, Wischnath H, Zug S, Peters A. Rise of ketone bodies with psychosocial stress in normal weight men. Psychoneuroendocrinology. 2014;45:43-48. doi:10.1016/j. psyneuen.2014. 03. 008. 25. Christopher MM, Broussard JD, Fallin CW, Drost NJ, Peterson ME. Increased serum d‑lactate associated with diabetic ketoacidosis. Metabolism. 1995;44(3):287-290. doi:10.1016/0026-0495(95)90156-6. 26. Bo J, Li W, Chen Z, Wadden DG, Randell E, Zhou H, et al. D‑lactate: a novel contributor to metabolic acidosis and high anion gap in diabetic ketoacidosis. Clin Chem. 2013 Sep;59(9):14067. doi: 10.1373/clinchem.2013.208777. Epub 2013 Jul 8. PMID: 23836843. 27. Lu J, Zello GA, Randell E, Adeli K, Krahn J, Meng QH. Closing the anion gap: Contribution of d‑lactate to diabetic ketoacidosis. Clin Chim Acta. 2011;412(3-4):286-291. doi:10.1016/j. cca 2010. 10. 020. 28. Stewart GW. Pyroglutamate acidosis 2023. A review of 100 cases. Clin Med Lond Engl. 2024;24(2):100030. doi:10.1016/j.clinme.2024.100030. 29. Douros A, Lix LM, Fralick M, Dell‚Aniello S, Shah BR, Ronksley PE, et al; Canadian Network for Observational Drug Effect Studies (CNODES) Investigators. Sodium‑Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis : A Multicenter Cohort Study. Ann Intern Med. 2020 Sep 15;173(6):417-425. doi: 10.7326/M20-0289. Epub 2020 Jul 28. PMID: 32716707. 30. Omar B, Ahrén B. Pleiotropic Mechanisms for the Glucose‑Lowering Action of DPP-4 Inhibitors. Diabetes. 2014;63(7):2196-2202. doi:10.2337/db14-0052. HLEDÁME Primáře na oddělení následné intenzivní péče Více informací k výběrovému řízení naleznete na WWW.ANESAN.CZ
RkJQdWJsaXNoZXIy NDA4Mjc=